TUESDAY, April 18, 2023 (HealthDay News) — A leading doctors’ group recommends that toddlers get screening for autism at 18 months old. That may not be a moment too soon — and earlier may be even better, researchers say. A new randomized clinical trial, the gold standard for studies, backsContinue Reading
TUESDAY, April 18, 2023 (HealthDay News) — Artificial intelligence (AI) may help clinicians diagnose tuberculosis in parts of the world where radiologists are scarce, a new study suggests. AI software successfully identified tuberculosis (TB) from cellphone photos of chest X-ray images, researchers reported at a European conference this week. “We’veContinue Reading
MONDAY, April 17, 2023 (HealthDay News) — An experimental blood test may be able to catch a dozen different types of cancer with a high degree of accuracy — including some that are particularly tricky to detect, a preliminary study suggests. Researchers found that the blood test was usually onContinue Reading
MONDAY, April 17, 2023 (HealthDay News) — New research in mice shows promise for a potential therapy for pancreatic cancer, which can be aggressive and hard to treat. Researchers from Houston Methodist tested a device that, while smaller than a grain of rice, could deliver immunotherapy directly into a pancreaticContinue Reading
FRIDAY, April 14, 2023 (HealthDay News) — Cutting-edge AI technologies that can detect subtle changes in a person’s voice may help doctors diagnose Alzheimer’s disease and other cognitive impairments even before other symptoms begin. In a new study, researchers used advanced machine learning and natural language processing (NLP) tools toContinue Reading
THURSDAY, April 13, 2023 (HealthDay News) — Whether the gender of a blood donor could affect the recipient’s survival was an unanswered question in medicine. Until now. “Some observational studies had suggested female donor blood might be linked with a higher risk of death among recipients compared to male donorContinue Reading
THURSDAY, April 13, 2023 (HealthDay News) — It’s not new for young people to develop an interest in their favorite pop singer or actor, but it can be problematic if that adoration turns toxic. It’s easier than ever to get lost in a celebrity’s carefully curated image via social mediaContinue Reading
TUESDAY, April 11, 2023 (HealthDay News) — Wireless pacemakers could be a safe and effective short-term option for children with slow heartbeats, a new study suggests. Children with a heartbeat that’s too slow — a condition called bradycardia — need a pacemaker to keep their hearts beating normally. Researchers successfullyContinue Reading
MONDAY, April 10, 2023 (HealthDay News) — ChatGPT, the AI chatbot everyone is talking about, can often give reliable answers to questions about breast cancer, a new study finds. But it’s not yet ready to replace your physician. The big caveat, researchers said, is that the information is not alwaysContinue Reading
THURSDAY, April 6, 2023 (HealthDay News) — Scientists have created an embryo-like structure using monkey embryonic stem cells for the first time, part of an effort to better understand early human development and organ formation. The researchers created the structures in a lab in China and then transferred them intoContinue Reading
WEDNESDAY, April 5, 2023 (HealthDay News) — It’s machine: 1, man: 0 in the latest battle between artificial intelligence (AI) technology and human health care pros. This time researchers set out to see if cardiologists could tell the difference between AI and a sonographer’s assessments of a key measure ofContinue Reading
WEDNESDAY, April 5, 2023 (HealthDay News) — A new national Alzheimer’s disease and dementia database could be a game changer for research on the memory-robbing condition that now affects more than 6 million Americans. Planning has begun at the National Institute on Aging (NIA) to fund the data platform. AContinue Reading
TUESDAY, April 4, 2023 (HealthDay News) — For women with “focal breast complaints” — issues with pain, lumps or discharge — ultrasound is an effective diagnostic tool, according to new research. These concerns are frequent, and ultrasound is effective as a standalone diagnostic method, researchers report April 4 in theContinue Reading
MONDAY, April 3, 2023 (HealthDay News) — An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says. Ficlatuzumab used in combination with the already approved targeted drug cetuximab (Erbitux) significantly improvedContinue Reading